{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:56:56Z","timestamp":1790312216145,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"NIH","award":["AG-20241, NS-50895 and NS-057395"],"award-info":[{"award-number":["AG-20241, NS-50895 and NS-057395"]}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"crossref","award":["IIRG-12-239626 and NIRG-13-281227"],"award-info":[{"award-number":["IIRG-12-239626 and NIRG-13-281227"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIA T32","award":["AG000096"],"award-info":[{"award-number":["AG000096"]}]},{"name":"University of California, Irvine Alzheimer's Disease Research Center","award":["P50 AG16573"],"award-info":[{"award-number":["P50 AG16573"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.neulet.2013.12.028","type":"journal-article","created":{"date-parts":[[2013,12,19]],"date-time":"2013-12-19T15:02:41Z","timestamp":1387465361000},"page":"86-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Immunogenicity of epitope vaccines targeting different B cell antigenic determinants of human \u03b1-synuclein: Feasibility study"],"prefix":"10.1016","volume":"560","author":[{"given":"Anahit","family":"Ghochikyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Petrushina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayk","family":"Davtyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armine","family":"Hovakimyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommy","family":"Saing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpine","family":"Davtyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Cribbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Agadjanyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2013.12.028_bib0005","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.4049\/jimmunol.174.3.1580","article-title":"Prototype Alzheimer's disease vaccine using the immunodominant B cell epitope from beta-amyloid and promiscuous T cell epitope pan HLA DR-binding peptide","volume":"174","author":"Agadjanyan","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.neulet.2013.12.028_bib0010","doi-asserted-by":"crossref","first-page":"13454","DOI":"10.1523\/JNEUROSCI.1292-12.2012","article-title":"Antibody-aided clearance of extracellular alpha-synuclein prevents cell-to-cell aggregate transmission","volume":"32","author":"Bae","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2013.12.028_bib0015","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nrn2477","article-title":"Research in motion: the enigma of Parkinson's disease pathology spread","volume":"9","author":"Brundin","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neulet.2013.12.028_bib0020","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.4049\/jimmunol.149.7.2385","article-title":"Immunogenic properties of multiple antigen peptide systems containing defined T and B epitopes","volume":"149","author":"Chai","year":"1992","journal-title":"J. Immunol."},{"key":"10.1016\/j.neulet.2013.12.028_bib0025","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.1523\/JNEUROSCI.4672-12.2013","article-title":"Immunogenicity, efficacy, safety, and mechanism of action of epitope vaccine (Lu AF20513) for Alzheimer's disease: prelude to a clinical trial","volume":"33","author":"Davtyan","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2013.12.028_bib0030","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nn2058","article-title":"A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides","volume":"11","author":"Gallardo","year":"2008","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neulet.2013.12.028_bib0035","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.4161\/hv.23875","article-title":"Refinement of a DNA based Alzheimer's disease epitope vaccine in rabbits","volume":"9","author":"Ghochikyan","year":"2013","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.neulet.2013.12.028_bib0040","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1385\/NMM:4:1-2:49","article-title":"Interactions of amyloidogenic proteins","volume":"4","author":"Giasson","year":"2003","journal-title":"Neuromolecular Med."},{"key":"10.1016\/j.neulet.2013.12.028_bib0045","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1007\/s12031-011-9576-5","article-title":"Immunotherapy for tauopathies","volume":"45","author":"Gu","year":"2011","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.neulet.2013.12.028_bib0050","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1172\/JCI43366","article-title":"Alpha-synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells","volume":"121","author":"Hansen","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neulet.2013.12.028_bib0055","first-page":"628070","article-title":"Targeting beta amyloid: a clinical review of immunotherapeutic approaches in Alzheimer's disease","volume":"2012","author":"Lobello","year":"2012","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1016\/j.neulet.2013.12.028_bib0060","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice","volume":"338","author":"Luk","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.neulet.2013.12.028_bib0065","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.neuron.2005.05.010","article-title":"Effects of alpha-synuclein immunization in a mouse model of Parkinson's disease","volume":"46","author":"Masliah","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.neulet.2013.12.028_bib0070","doi-asserted-by":"crossref","first-page":"e19338","DOI":"10.1371\/journal.pone.0019338","article-title":"Passive immunization reduces behavioral and neuropathological deficits in an alpha-synuclein transgenic model of Lewy body disease","volume":"6","author":"Masliah","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neulet.2013.12.028_bib0075","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.expneurol.2008.04.008","article-title":"The alpha-synuclein burden hypothesis of Parkinson disease and its relationship to Alzheimer disease","volume":"212","author":"McGeer","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neulet.2013.12.028_bib0080","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1371\/journal.pone.0002124","article-title":"Reducing AD-like pathology in 3xTg-AD mouse model by DNA epitope vaccine\u2014a novel immunotherapeutic strategy","volume":"3","author":"Movsesyan","year":"2008","journal-title":"PLos ONE"},{"key":"10.1016\/j.neulet.2013.12.028_bib0085","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.expneurol.2007.11.019","article-title":"Relationship of phosphorylated alpha-synuclein and tau accumulation to Abeta deposition in the cerebral cortex of Dementia with Lewy bodies","volume":"210","author":"Obi","year":"2008","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.neulet.2013.12.028_bib0090","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/01.WNL.0000073623.84147.A8","article-title":"Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization","volume":"61","author":"Orgogozo","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2013.12.028_bib0095","doi-asserted-by":"crossref","first-page":"12721","DOI":"10.1523\/JNEUROSCI.3201-07.2007","article-title":"Alzheimer's disease peptide epitope vaccine reduces insoluble but not soluble\/oligomeric A{beta} species in amyloid precursor protein transgenic mice","volume":"27","author":"Petrushina","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2013.12.028_bib0100","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/22124","article-title":"Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse","volume":"400","author":"Schenk","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.neulet.2013.12.028_bib0105","doi-asserted-by":"crossref","first-page":"5409","DOI":"10.1073\/pnas.85.15.5409","article-title":"Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system","volume":"85","author":"Tam","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neulet.2013.12.028_bib0110","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S1474-4422(11)70213-7","article-title":"Pathological roles of alpha-synuclein in neurological disorders","volume":"10","author":"Vekrellis","year":"2011","journal-title":"Lancet Neurol."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394013011099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394013011099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T20:18:04Z","timestamp":1759609084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394013011099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":22,"alternative-id":["S0304394013011099"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2013.12.028","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity of epitope vaccines targeting different B cell antigenic determinants of human \u03b1-synuclein: Feasibility study","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2013.12.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}